Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients
The heterogeneous nature of inflammatory bowel disease (IBD) presents challenges, particularly when choosing therapy. Activation of the NF-κB transcription factor is a highly regulated, dynamic event in IBD pathogenesis. Using a lentivirus approach, NF-κB-regulated luciferase was expressed in patien...
Main Authors: | , , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-09-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2019.02168/full |
id |
doaj-d581931c5d434a78a70223703dfa1143 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Stamatia Papoutsopoulou Stamatia Papoutsopoulou Michael D. Burkitt François Bergey Hazel England Rachael Hough Lorraine Schmidt David G. Spiller Michael H. R. White Pawel Paszek Dean A. Jackson Vitor A. P. Martins Dos Santos Vitor A. P. Martins Dos Santos Gernot Sellge D. Mark Pritchard Barry J. Campbell Werner Müller Chris S. Probert |
spellingShingle |
Stamatia Papoutsopoulou Stamatia Papoutsopoulou Michael D. Burkitt François Bergey Hazel England Rachael Hough Lorraine Schmidt David G. Spiller Michael H. R. White Pawel Paszek Dean A. Jackson Vitor A. P. Martins Dos Santos Vitor A. P. Martins Dos Santos Gernot Sellge D. Mark Pritchard Barry J. Campbell Werner Müller Chris S. Probert Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients Frontiers in Immunology inflammatory bowel disease NF-κB macrophages cytokines Crohn's disease ulcerative colitis |
author_facet |
Stamatia Papoutsopoulou Stamatia Papoutsopoulou Michael D. Burkitt François Bergey Hazel England Rachael Hough Lorraine Schmidt David G. Spiller Michael H. R. White Pawel Paszek Dean A. Jackson Vitor A. P. Martins Dos Santos Vitor A. P. Martins Dos Santos Gernot Sellge D. Mark Pritchard Barry J. Campbell Werner Müller Chris S. Probert |
author_sort |
Stamatia Papoutsopoulou |
title |
Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients |
title_short |
Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients |
title_full |
Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients |
title_fullStr |
Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients |
title_full_unstemmed |
Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease Patients |
title_sort |
macrophage-specific nf-κb activation dynamics can segregate inflammatory bowel disease patients |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Immunology |
issn |
1664-3224 |
publishDate |
2019-09-01 |
description |
The heterogeneous nature of inflammatory bowel disease (IBD) presents challenges, particularly when choosing therapy. Activation of the NF-κB transcription factor is a highly regulated, dynamic event in IBD pathogenesis. Using a lentivirus approach, NF-κB-regulated luciferase was expressed in patient macrophages, isolated from frozen peripheral blood mononuclear cell samples. Following activation, samples could be segregated into three clusters based on the NF-κB-regulated luciferase response. The ulcerative colitis (UC) samples appeared only in the hypo-responsive Cluster 1, and in Cluster 2. Conversely, Crohn's disease (CD) patients appeared in all Clusters with their percentage being higher in the hyper-responsive Cluster 3. A positive correlation was seen between NF-κB-induced luciferase activity and the concentrations of cytokines released into medium from stimulated macrophages, but not with serum or biopsy cytokine levels. Confocal imaging of lentivirally-expressed p65 activation revealed that a higher proportion of macrophages from CD patients responded to endotoxin lipid A compared to controls. In contrast, cells from UC patients exhibited a shorter duration of NF-κB p65 subunit nuclear localization compared to healthy controls, and CD donors. Analysis of macrophage cytokine responses and patient metadata revealed a strong correlation between CD patients who smoked and hyper-activation of p65. These in vitro dynamic assays of NF-κB activation in blood-derived macrophages have the potential to segregate IBD patients into groups with different phenotypes and may therefore help determine response to therapy. |
topic |
inflammatory bowel disease NF-κB macrophages cytokines Crohn's disease ulcerative colitis |
url |
https://www.frontiersin.org/article/10.3389/fimmu.2019.02168/full |
work_keys_str_mv |
AT stamatiapapoutsopoulou macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT stamatiapapoutsopoulou macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT michaeldburkitt macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT francoisbergey macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT hazelengland macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT rachaelhough macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT lorraineschmidt macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT davidgspiller macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT michaelhrwhite macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT pawelpaszek macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT deanajackson macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT vitorapmartinsdossantos macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT vitorapmartinsdossantos macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT gernotsellge macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT dmarkpritchard macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT barryjcampbell macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT wernermuller macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients AT chrissprobert macrophagespecificnfkbactivationdynamicscansegregateinflammatoryboweldiseasepatients |
_version_ |
1725112850756665344 |
spelling |
doaj-d581931c5d434a78a70223703dfa11432020-11-25T01:25:38ZengFrontiers Media S.A.Frontiers in Immunology1664-32242019-09-011010.3389/fimmu.2019.02168473700Macrophage-Specific NF-κB Activation Dynamics Can Segregate Inflammatory Bowel Disease PatientsStamatia Papoutsopoulou0Stamatia Papoutsopoulou1Michael D. Burkitt2François Bergey3Hazel England4Rachael Hough5Lorraine Schmidt6David G. Spiller7Michael H. R. White8Pawel Paszek9Dean A. Jackson10Vitor A. P. Martins Dos Santos11Vitor A. P. Martins Dos Santos12Gernot Sellge13D. Mark Pritchard14Barry J. Campbell15Werner Müller16Chris S. Probert17Department of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United KingdomFaculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, United KingdomDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United KingdomLifeGlimmer GmbH, Berlin, GermanyFaculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, United KingdomDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United KingdomFaculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, United KingdomFaculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, United KingdomFaculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, United KingdomFaculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, United KingdomFaculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, United KingdomLifeGlimmer GmbH, Berlin, GermanyDepartment of Agrotechnology and Food Sciences, Wageningen University, Wageningen, NetherlandsUniversity Hospital RWTH Aachen, Aachen, GermanyDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United KingdomDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United KingdomFaculty of Biology, Medicine and Health, School of Biological Sciences, University of Manchester, Manchester, United KingdomDepartment of Cellular and Molecular Physiology, Institute of Translational Medicine, University of Liverpool, Liverpool, United KingdomThe heterogeneous nature of inflammatory bowel disease (IBD) presents challenges, particularly when choosing therapy. Activation of the NF-κB transcription factor is a highly regulated, dynamic event in IBD pathogenesis. Using a lentivirus approach, NF-κB-regulated luciferase was expressed in patient macrophages, isolated from frozen peripheral blood mononuclear cell samples. Following activation, samples could be segregated into three clusters based on the NF-κB-regulated luciferase response. The ulcerative colitis (UC) samples appeared only in the hypo-responsive Cluster 1, and in Cluster 2. Conversely, Crohn's disease (CD) patients appeared in all Clusters with their percentage being higher in the hyper-responsive Cluster 3. A positive correlation was seen between NF-κB-induced luciferase activity and the concentrations of cytokines released into medium from stimulated macrophages, but not with serum or biopsy cytokine levels. Confocal imaging of lentivirally-expressed p65 activation revealed that a higher proportion of macrophages from CD patients responded to endotoxin lipid A compared to controls. In contrast, cells from UC patients exhibited a shorter duration of NF-κB p65 subunit nuclear localization compared to healthy controls, and CD donors. Analysis of macrophage cytokine responses and patient metadata revealed a strong correlation between CD patients who smoked and hyper-activation of p65. These in vitro dynamic assays of NF-κB activation in blood-derived macrophages have the potential to segregate IBD patients into groups with different phenotypes and may therefore help determine response to therapy.https://www.frontiersin.org/article/10.3389/fimmu.2019.02168/fullinflammatory bowel diseaseNF-κBmacrophagescytokinesCrohn's diseaseulcerative colitis |